Cargando…

Generation of an inactivated vaccine for avian pathogenic Escherichia coli using microarrays: A more rational approach to inactivated vaccine design

BACKGROUND: Escherichia coli remains a major pathogen of poultry. Most vaccines are inactivated and produced empirically. Although inactivated Salmonella vaccines have been produced by culture under conditions of Fe deprivation, no vaccines have been produced which are likely to express all the prot...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Xiangmei, Richards, Philip, Windhorst, Daniel, Imre, Ariel, Bukovinski, Agnes, Ruggeri, Jessica, Elazomi, Altayeb, Barrow, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Faculty of Veterinary Medicine 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109846/
https://www.ncbi.nlm.nih.gov/pubmed/35603079
http://dx.doi.org/10.5455/OVJ.2022.v12.i2.10
_version_ 1784708967512932352
author Zhou, Xiangmei
Richards, Philip
Windhorst, Daniel
Imre, Ariel
Bukovinski, Agnes
Ruggeri, Jessica
Elazomi, Altayeb
Barrow, Paul
author_facet Zhou, Xiangmei
Richards, Philip
Windhorst, Daniel
Imre, Ariel
Bukovinski, Agnes
Ruggeri, Jessica
Elazomi, Altayeb
Barrow, Paul
author_sort Zhou, Xiangmei
collection PubMed
description BACKGROUND: Escherichia coli remains a major pathogen of poultry. Most vaccines are inactivated and produced empirically. Although inactivated Salmonella vaccines have been produced by culture under conditions of Fe deprivation, no vaccines have been produced which are likely to express all the proteins expressed during infection of antigen-presenting cells. AIM: The aim was to produce a more protective inactivated vaccine by culturing the avian E. coli in a synthetic medium that resembled the environment of the phagolysosome. METHODS: Global gene expression in a pathogenic avian O78:K80 strain of E. coli, harvested from infected avian macrophage-like HD11 cells, was compared by microarray with bacteria cultured in a tissue culture medium. A liquid synthetic medium was produced based on the environmental conditions identified to which the bacteria were exposed intracellularly. A bacterin was produced from this strain and its protective ability was assessed in chickens. RESULTS: The changes in E. coli gene expression observed included the use of different electron acceptors and carbon sources such as ethanolamine, β-glucosides, galactonate, dicarboxylic acids, and amino acids, up-regulation of genes associated with Fe and Mn uptake, and up-regulation of type-1 and curli fimbriae, other adhesion genes and down-regulation of sialic acid synthesis genes. The bacterin produced in the synthetic medium was statistically more protective than a bacterin prepared from bacteria cultured in the nutrient broth when tested in vaccinated chickens challenged with a different virulent E. coli O78:K80 strain. CONCLUSION: The approach of using gene expression to produce synthetic media for the generation of more effective bacterins could be used for a number of intracellular bacteria pathogens including Enteroinvasive E. coli, Salmonella, and the Pasteurella/Riemerella/Mannheimia group of organisms.
format Online
Article
Text
id pubmed-9109846
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Faculty of Veterinary Medicine
record_format MEDLINE/PubMed
spelling pubmed-91098462022-05-21 Generation of an inactivated vaccine for avian pathogenic Escherichia coli using microarrays: A more rational approach to inactivated vaccine design Zhou, Xiangmei Richards, Philip Windhorst, Daniel Imre, Ariel Bukovinski, Agnes Ruggeri, Jessica Elazomi, Altayeb Barrow, Paul Open Vet J Original Research BACKGROUND: Escherichia coli remains a major pathogen of poultry. Most vaccines are inactivated and produced empirically. Although inactivated Salmonella vaccines have been produced by culture under conditions of Fe deprivation, no vaccines have been produced which are likely to express all the proteins expressed during infection of antigen-presenting cells. AIM: The aim was to produce a more protective inactivated vaccine by culturing the avian E. coli in a synthetic medium that resembled the environment of the phagolysosome. METHODS: Global gene expression in a pathogenic avian O78:K80 strain of E. coli, harvested from infected avian macrophage-like HD11 cells, was compared by microarray with bacteria cultured in a tissue culture medium. A liquid synthetic medium was produced based on the environmental conditions identified to which the bacteria were exposed intracellularly. A bacterin was produced from this strain and its protective ability was assessed in chickens. RESULTS: The changes in E. coli gene expression observed included the use of different electron acceptors and carbon sources such as ethanolamine, β-glucosides, galactonate, dicarboxylic acids, and amino acids, up-regulation of genes associated with Fe and Mn uptake, and up-regulation of type-1 and curli fimbriae, other adhesion genes and down-regulation of sialic acid synthesis genes. The bacterin produced in the synthetic medium was statistically more protective than a bacterin prepared from bacteria cultured in the nutrient broth when tested in vaccinated chickens challenged with a different virulent E. coli O78:K80 strain. CONCLUSION: The approach of using gene expression to produce synthetic media for the generation of more effective bacterins could be used for a number of intracellular bacteria pathogens including Enteroinvasive E. coli, Salmonella, and the Pasteurella/Riemerella/Mannheimia group of organisms. Faculty of Veterinary Medicine 2022 2022-04-04 /pmc/articles/PMC9109846/ /pubmed/35603079 http://dx.doi.org/10.5455/OVJ.2022.v12.i2.10 Text en https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Zhou, Xiangmei
Richards, Philip
Windhorst, Daniel
Imre, Ariel
Bukovinski, Agnes
Ruggeri, Jessica
Elazomi, Altayeb
Barrow, Paul
Generation of an inactivated vaccine for avian pathogenic Escherichia coli using microarrays: A more rational approach to inactivated vaccine design
title Generation of an inactivated vaccine for avian pathogenic Escherichia coli using microarrays: A more rational approach to inactivated vaccine design
title_full Generation of an inactivated vaccine for avian pathogenic Escherichia coli using microarrays: A more rational approach to inactivated vaccine design
title_fullStr Generation of an inactivated vaccine for avian pathogenic Escherichia coli using microarrays: A more rational approach to inactivated vaccine design
title_full_unstemmed Generation of an inactivated vaccine for avian pathogenic Escherichia coli using microarrays: A more rational approach to inactivated vaccine design
title_short Generation of an inactivated vaccine for avian pathogenic Escherichia coli using microarrays: A more rational approach to inactivated vaccine design
title_sort generation of an inactivated vaccine for avian pathogenic escherichia coli using microarrays: a more rational approach to inactivated vaccine design
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109846/
https://www.ncbi.nlm.nih.gov/pubmed/35603079
http://dx.doi.org/10.5455/OVJ.2022.v12.i2.10
work_keys_str_mv AT zhouxiangmei generationofaninactivatedvaccineforavianpathogenicescherichiacoliusingmicroarraysamorerationalapproachtoinactivatedvaccinedesign
AT richardsphilip generationofaninactivatedvaccineforavianpathogenicescherichiacoliusingmicroarraysamorerationalapproachtoinactivatedvaccinedesign
AT windhorstdaniel generationofaninactivatedvaccineforavianpathogenicescherichiacoliusingmicroarraysamorerationalapproachtoinactivatedvaccinedesign
AT imreariel generationofaninactivatedvaccineforavianpathogenicescherichiacoliusingmicroarraysamorerationalapproachtoinactivatedvaccinedesign
AT bukovinskiagnes generationofaninactivatedvaccineforavianpathogenicescherichiacoliusingmicroarraysamorerationalapproachtoinactivatedvaccinedesign
AT ruggerijessica generationofaninactivatedvaccineforavianpathogenicescherichiacoliusingmicroarraysamorerationalapproachtoinactivatedvaccinedesign
AT elazomialtayeb generationofaninactivatedvaccineforavianpathogenicescherichiacoliusingmicroarraysamorerationalapproachtoinactivatedvaccinedesign
AT barrowpaul generationofaninactivatedvaccineforavianpathogenicescherichiacoliusingmicroarraysamorerationalapproachtoinactivatedvaccinedesign